Dr Anna Bajera is a graduate of the first Faculty of Medicine at the Medical University of Warsaw. For 19 years she has been professionally associated with the clinical research industry. She worked at both global pharmaceutical companies (Novartis, GSK) and CRO (PPD, InventivHealth). During many years of work, she was responsible for monitoring, managing international, multicenter clinical trials and supervising their quality. She also participated in the creation and development of the branch of the Italian CRO in Poland (OPIS), as well as the Clinical Research Development Center in the newly established public institution – Medical Research Agency (MRA). Projects on which she worked at MRA, such as: development of Clinical Research Support Centers; Patient in clinical trials; The Clinical Research Academy will contribute to the removal of barriers to the development of clinical trials in Poland. She also participated in the work on the Act on Clinical Trials (which is to enable the application of EU Regulation 536/2014 in our country),she chaired the work of the non-commercial research group and initiated Poland’s cooperation with the ECRIN network, which brings together scientific partners in Europe. After the creation of the Polish part of the network – POLCRIN , she was a representative in the ECRIN Members’ Assembly.